- Home
- AACG vs IXHL Comparison
AACG vs IXHL Comparison
Compare AACG & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- IXHL
- Stock Information
- Founded
- AACG 1999
- IXHL 2001
- Country
- AACG China
- IXHL Australia
- Employees
- AACG N/A
- IXHL N/A
- Industry
- AACG Other Consumer Services
- IXHL
- Sector
- AACG Real Estate
- IXHL
- Exchange
- AACG Nasdaq
- IXHL Nasdaq
- Market Cap
- AACG 51.9M
- IXHL 49.1M
- IPO Year
- AACG N/A
- IXHL N/A
- Fundamental
- Price
- AACG $1.09
- IXHL $0.36
- Analyst Decision
- AACG
- IXHL
- Analyst Count
- AACG 0
- IXHL 0
- Target Price
- AACG N/A
- IXHL N/A
- AVG Volume (30 Days)
- AACG 23.8K
- IXHL 17.0M
- Earning Date
- AACG 11-12-2025
- IXHL 11-14-2025
- Dividend Yield
- AACG N/A
- IXHL N/A
- EPS Growth
- AACG N/A
- IXHL N/A
- EPS
- AACG N/A
- IXHL N/A
- Revenue
- AACG $39,316,403.00
- IXHL $12,000.00
- Revenue This Year
- AACG N/A
- IXHL $1,188.37
- Revenue Next Year
- AACG N/A
- IXHL $3,569.49
- P/E Ratio
- AACG N/A
- IXHL N/A
- Revenue Growth
- AACG 11.62
- IXHL N/A
- 52 Week Low
- AACG $0.70
- IXHL $0.08
- 52 Week High
- AACG $2.58
- IXHL $2.25
- Technical
- Relative Strength Index (RSI)
- AACG 43.43
- IXHL 49.50
- Support Level
- AACG $1.18
- IXHL $0.30
- Resistance Level
- AACG $1.36
- IXHL $0.34
- Average True Range (ATR)
- AACG 0.11
- IXHL 0.02
- MACD
- AACG -0.00
- IXHL 0.00
- Stochastic Oscillator
- AACG 33.33
- IXHL 75.98
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.